Condition: COPD · Chronic Obstructive Pulmonary Disease · Sponsor: Nuvaira, Inc.
The dNerva Lung Denervation System is one-time treatment intended to improve breathing in Chronic Obstructive Pulmonary Disease (COPD) patients on standard medical care. The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System in the treatment of COPD.
This description comes directly from the study's public registry record.
John Carline · 763-450-2819 · jcarline@nuvaira.com
Angie McFadden · 763-450-2825 · amcfadden@nuvaira.com
Always discuss trial participation with your own doctor first.
| University of Alabama-Birmingham Hospital - UAB Lung Health Center | Birmingham, Alabama, United States | Recruiting |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Henry Ford Hospital - Lung and Pulmonary Care | Detroit, Michigan, United States | Recruiting |
| Wake Forest School of Medicine | Salem, North Carolina, United States | Not Yet Recruiting |
| Ohio State University Medical Center - Ohio State Lung Center | Columbus, Ohio, United States | Recruiting |
| Penn Highlands - Lung Innovations/Clinical Research Associates | DuBois, Pennsylvania, United States | Recruiting |
| Temple University - Temple Lung Center | Philadelphia, Pennsylvania, United States | Recruiting |
| University of Pittsburgh Medical Center - UMPC Comprehensive Lung Center | Pittsburgh, Pennsylvania, United States | Not Yet Recruiting |
| Virginia Commonwealth University Health System | Richmond, Virginia, United States | Not Yet Recruiting |
| Medical College of Wisconsin | Milwaukee, Wisconsin, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07051707